In addition, metastatic ovarian lesions in breast cancer sometimes mimic the clinical and histological features of primary ovarian cancer and even lose the characteristic oestrogen receptor (ER) and progesterone receptor (PR) expression levels [12,13]. This evidence concerns the gene ESR1 and breast carcinoma.